NeoDocs is a Mumbai health-tech company that turns a smartphone into a diagnostic reader. Users dip a paper test card in a urine sample, scan it with the NeoDocs app, and get lab-referenced results in under a minute - covering kidney, metabolic and general wellness markers. Founded by three IIT Bombay alumni and backed by Y Combinator (S21) and Omidyar Network India, it sells test kits direct to consumers and works with thousands of doctors across India.
Ria Health is a San Francisco-based telehealth company that treats alcohol use disorder entirely online. Founded in 2015 by addiction physician Dr. John Mendelson, it combines FDA-approved anti-craving medications (including naltrexone and The Sinclair Method), recovery coaching, digital progress tracking and a smartphone breathalyzer into a physician-managed program available in all 50 states. Ria treats drinking as a medical condition rather than a moral failing, offering flexible goals from moderation to abstinence, with care reimbursed by major insurers.
Wesper is a New York-based sleep-health company that has built a wireless, wearable patch and cloud platform for clinical-grade, at-home sleep apnea testing. Founded in 2017 (originally as Tatch) by Dr. Amir Reuveny and Adi Mordechai, Wesper combines flexible printed electronics, machine learning, and a provider portal to replace the wires and single-night snapshots of traditional sleep labs with comfortable, repeatable, longitudinal testing. The FDA-cleared Wesper Lab lets patients test at home while giving physicians high-resolution data that correlates closely with in-lab polysomnography.
Doctronic is a New York-based health technology company building an AI-native primary care platform. Its free, anonymous AI doctor gives instant symptom assessments and treatment guidance grounded in peer-reviewed research, and connects patients to licensed physicians for $39 video visits or an insurance copay. Founded in 2023 by technologist Matt Pavelle and vascular surgeon Dr. Adam Oskowitz, the company has processed more than 15 million medical conversations, became the first AI to legally renew prescriptions in the U.S. under Utah's regulatory sandbox, and has raised $65 million across three rounds in under a year.
Conceive is a New York-based virtual fertility company that acts as an always-on care layer wrapped around the fertility and pregnancy journey. Founded in 2021 by Lauren Berson after her own three-year struggle with infertility, it pairs 24/7 nurse and coach support with cohort-based community and evidence-based education. Members reach a real person - a nurse, coach, or dietitian - in minutes rather than waiting weeks for a clinic callback, and the company sells both direct-to-consumer subscriptions and a B2B layer to fertility clinics.
Genetica is a San Francisco-founded gene decoding company built for Asian genomes. It pairs a proprietary genotyping chip - manufactured with Illumina and Thermo Fisher - with AI analysis to turn a saliva sample into reports on health risks, innate ability, behavior, nutrition and fitness. Marketed direct-to-consumer across Vietnam and Southeast Asia, its CLIA- and CAP-certified pipeline is reviewed by scientists tied to UCSF, Harvard, Stanford and Cornell.
GenieMD is a San Ramon, California virtual care company that sells a single, white-label platform folding together telehealth, remote patient monitoring, remote therapeutic monitoring and chronic care management - plus built-in e-prescriptions, lab integration and CPT billing reports. Founded in 2010 by Stanford-trained engineer Soheil Saadat, it sells to hospitals, health systems, group practices, insurers, ACOs and employers, and in 2026 launched HelloGenie, a free AI doctor that hands patients off to real board-certified physicians when actual care is needed. Frost & Sullivan named it 2024 Company of the Year for virtual chronic disease management.
HueDx is a Philadelphia diagnostics company - formerly Group K Diagnostics - that turns any smartphone camera into a reader for lab-grade, quantitative color-based tests. Its patented HueCard color-correction hardware and AI-powered HueTools/HueCloud software let researchers develop, validate, and deploy paper-based colorimetric assays without proprietary readers or lab infrastructure, aiming to make quantitative results available at the point of care and at home.
The Lanby is a membership-based, hospitality-led primary care practice in New York City that reimagines concierge medicine for a modern, prevention-minded patient. Founded in 2021 by breast cancer survivor Chloe Harrouche, it pairs every member with a dedicated care team - a lead physician, wellness advisor, medical assistant, physician associate, and member advocate - to connect the dots across medicine, wellness, and care coordination. For a flat annual fee and no insurance friction, members get unlimited visits, advanced diagnostics with 85+ biomarkers, personalized care plans, and expedited specialist referrals.
Pandia Health is a doctor-founded, women-led telehealth company that prescribes and delivers birth control, acne treatment, and menopause hormone therapy across the United States. Founded in 2016 by Stanford-affiliated physician Dr. Sophia Yen and a team of clinicians and operators, the company built its business on a simple bet: most American women still struggle to get continuous access to hormonal medication, and a recurring, mail-order subscription paired with a board-certified physician network can fix it.
Teal Health is a San Francisco women's health company behind the Teal Wand, the first and only FDA-authorized at-home self-collection device for cervical cancer screening. Founded by Stanford physician-researcher Dr. Avnesh Thakor and CEO Kara Egan, the company pairs a comfortable, tampon-like self-collection device with a women's telehealth platform so people with a cervix can screen for HPV at home and skip the stirrups. The device uses the same clinically validated Roche cobas HPV test that providers use in-clinic, detecting cervical precancer 96% of the time, and shipped nationwide to all 50 states after winning FDA authorization in May 2025.
Lifeforce is a personalized health optimization and longevity-medicine platform that pairs at-home blood diagnostics measuring 40-50+ biomarkers with telehealth consults, a personal health coach, and tailored interventions including supplements, hormone protocols, and prescription medication. Co-founded in 2021 by Tony Robbins, Dr. Peter Diamandis, Dugal Bain-Kim, and Joel Jackson, the company aims to help people in midlife take a proactive, data-driven approach to feeling and functioning better rather than waiting for disease to show up.
Summer Health is a New York-based pediatric care company that gives parents access to board-certified pediatricians by text message, with answers in about 15 minutes, day or night. Founded in 2022 by Ellen DaSilva and Matthew Woo, it pairs a 24/7 text line with specialists in sleep, nutrition and lactation, and has expanded into longitudinal pediatric primary care - including a comprehensive children's blood panel reviewed by a pediatrician. The company aims to be the calm, always-on front door for family health.
Tiny Health is an Austin-based health company that built the first at-home gut microbiome test designed for babies, then extended the same clinically-validated science to children, pregnant people, adults and longevity. It pairs DNA sequencing of stool and vaginal samples with age-specific reference ranges and personalized, research-backed recommendations, aiming to catch early microbiome imbalances linked to eczema, allergies, digestive issues and chronic conditions before they take hold.
Impress is a Barcelona-based orthodontic company building Europe's largest chain of clear-aligner clinics. Founded in 2019, it pairs in-clinic, orthodontist-led treatment with AI-driven planning and remote digital monitoring to make discreet teeth straightening faster, more convenient, and more affordable. After acquiring DrSmile in 2024, Impress operates over 110 clinics across roughly ten countries in Europe and the United States.
Orchid is a reproductive genetics company offering the first commercially available whole-genome sequencing test for IVF embryos. Founded by Noor Siddiqui in 2019, Orchid reads more than 99% of an embryo's genome before implantation and screens for over 1,200 monogenic conditions, chromosomal abnormalities, de novo mutations, and polygenic disease risk - so prospective parents can make informed choices before pregnancy begins.